← Back to Search

Platelet Rich Plasma

PRP Injection for Sexual Function (VIP Trial)

N/A
Recruiting
Led By Alexis Dieter, MD
Research Sponsored by Medstar Health Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months
Awards & highlights

VIP Trial Summary

This trial will look at whether an injection of platelet-rich plasma can improve sexual satisfaction & function. Participants will get either the injection or a placebo & answer questionnaires. Investigators will compare the two groups. #ClinicalTrial #PRP

Who is the study for?
This trial is for English-speaking women between 18 and 45 years old who are sexually active, either with a partner or through solo activities. They must be able to follow the study's requirements.Check my eligibility
What is being tested?
The trial is testing if injecting platelet rich plasma (PRP) into the vaginal wall and around the clitoris can improve sexual satisfaction compared to a placebo saline injection. Participants will receive one injection and answer questionnaires about their sexual function.See study design
What are the potential side effects?
Potential side effects of PRP injections may include temporary pain at the injection site, bleeding, bruising, infection, or an allergic reaction. However, since PRP uses the patient's own blood components, risks are generally considered low.

VIP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Sexual Function
Secondary outcome measures
Overall effect
Pain with Injection
Sexual Dysfunction

VIP Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Platelet Rich PlasmaActive Control1 Intervention
Platelet Rich Plasma Injection
Group II: SalinePlacebo Group1 Intervention
Placebo injection of saline

Find a Location

Who is running the clinical trial?

Medstar Health Research InstituteLead Sponsor
189 Previous Clinical Trials
115,521 Total Patients Enrolled
The Patty Brisben Foundation for Women's Sexual HealthUNKNOWN
Alexis Dieter, MDPrincipal InvestigatorMedstar Health Research Institute
1 Previous Clinical Trials
29 Total Patients Enrolled

Media Library

Platelet Rich Plasma (Platelet Rich Plasma) Clinical Trial Eligibility Overview. Trial Name: NCT05769283 — N/A
Sexual Activity Clinical Trial 2023: Platelet Rich Plasma Highlights & Side Effects. Trial Name: NCT05769283 — N/A
Platelet Rich Plasma (Platelet Rich Plasma) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05769283 — N/A
Sexual Activity Research Study Groups: Saline, Platelet Rich Plasma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research program include participants of forty-five or more years?

"The investigators of this trial are seeking participants age 18-59."

Answered by AI

Are any new participants being enlisted for this medical experiment?

"The search for patients is still ongoing as per information posted on clinicaltrials.gov, which was last updated in May 16th of 2023 and originally posted 5/1/2023."

Answered by AI

How many individuals have opted to participate in this experiment?

"Yes, as per the information provided on clinicaltrials.gov, this medical trial is currently looking for enrolment from 1 site and 52 patients in total. This research was first published on May 1st 2023 with a last edit occurring 16 days later."

Answered by AI

Who meets the eligibility requirements for participating in this research?

"In order to be eligible for this research, candidates must have engaged in sexual intercourse and fall within the age bracket of 18-59. Up to 52 participants are being admitted into the trial."

Answered by AI
~0 spots leftby May 2024